Last update 17 Mar 2026

Glycol Salicylate/L-Menthol/Vanillyl Nonylamide

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
SINSINPASNEWGENGEL, 신신파스뉴젠겔
Target
TRPA1 x TRPM8 x κ opioid receptor
Action
inhibitors, agonists, antagonists
Mechanism
TRPA1 inhibitors(Transient receptor potential cation channel subfamily A member 1 inhibitors), TRPM8 agonists(Transient receptor potential cation channel subfamily M member 8 agonists), κ opioid receptor antagonists(Kappa opioid receptor antagonists)
Therapeutic Areas
Nervous System DiseasesSkin and Musculoskeletal DiseasesOther Diseases
Active Indication
InflammationInsect Bites and StingsPain+ [1]
Inactive Indication-
Originator Organization
Sinsin Pharmaceutical Co., Ltd.Sinsin Pharmaceutical Co., Ltd.
Active Organization
Sinsin Pharmaceutical Co., Ltd.Sinsin Pharmaceutical Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhaseApproved
First Approval Date
South Korea (23 Feb 2026),
InflammationInsect Bites and StingsPain+ [1]
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC9H10O4
InChIKeyLVYLCBNXHHHPSB-UHFFFAOYSA-N
CAS Registry87-28-5
View All Structures (2)

Related

100 Clinical Results associated with Glycol Salicylate/L-Menthol/Vanillyl Nonylamide
Login to view more data
100 Translational Medicine associated with Glycol Salicylate/L-Menthol/Vanillyl Nonylamide
Login to view more data
100 Patents (Medical) associated with Glycol Salicylate/L-Menthol/Vanillyl Nonylamide
Login to view more data
100 Deals associated with Glycol Salicylate/L-Menthol/Vanillyl Nonylamide
Login to view more data

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Inflammation
South Korea
Sinsin Pharmaceutical Co., Ltd.Sinsin Pharmaceutical Co., Ltd.
23 Feb 2026
Insect Bites and Stings
South Korea
Sinsin Pharmaceutical Co., Ltd.Sinsin Pharmaceutical Co., Ltd.
23 Feb 2026
Pain
South Korea
Sinsin Pharmaceutical Co., Ltd.Sinsin Pharmaceutical Co., Ltd.
23 Feb 2026
Pruritis (itchy skin)
South Korea
Sinsin Pharmaceutical Co., Ltd.Sinsin Pharmaceutical Co., Ltd.
23 Feb 2026
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free